177 related articles for article (PubMed ID: 35989364)
1. Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma.
Laheurte C; Seffar E; Gravelin E; Lecuelle J; Renaudin A; Boullerot L; Malfroy M; Marguier A; Lecoester B; Gaugler B; Saas P; Truntzer C; Ghiringhelli F; Adotevi O
Cancer Immunol Immunother; 2023 Mar; 72(3):579-589. PubMed ID: 35989364
[TBL] [Abstract][Full Text] [Related]
2. A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients.
Hannani D; Leplus E; Laurin D; Caulier B; Aspord C; Madelon N; Bourova-Flin E; Brambilla C; Brambilla E; Toffart AC; Laulagnier K; Chaperot L; Plumas J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768214
[TBL] [Abstract][Full Text] [Related]
3. The differentiation of new human CD303
Zhong Q; Lu Y; Xu W; Rong Z; Chang X; Qin L; Chen X; Zhou F
Int Immunopharmacol; 2021 Oct; 99():107983. PubMed ID: 34298400
[TBL] [Abstract][Full Text] [Related]
4. The Tumor Milieu Promotes Functional Human Tumor-Resident Plasmacytoid Dendritic Cells in Humanized Mouse Models.
Maser IP; Hoves S; Bayer C; Heidkamp G; Nimmerjahn F; Eckmann J; Ries CH
Front Immunol; 2020; 11():2082. PubMed ID: 33013879
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of plasmacytoid dendritic cell is associated with a treatment response to DNA-damaging treatment and favorable prognosis in lung adenocarcinoma.
Cha YJ; Kim EY; Choi YJ; Kim CY; Park MK; Chang YS
Front Immunol; 2023; 14():1154881. PubMed ID: 37435086
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer.
Kießler M; Plesca I; Sommer U; Wehner R; Wilczkowski F; Müller L; Tunger A; Lai X; Rentsch A; Peuker K; Zeissig S; Seifert AM; Seifert L; Weitz J; Bachmann M; Bornhäuser M; Aust D; Baretton G; Schmitz M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762320
[TBL] [Abstract][Full Text] [Related]
7. An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial.
Charles J; Chaperot L; Hannani D; Bruder Costa J; Templier I; Trabelsi S; Gil H; Moisan A; Persoons V; Hegelhofer H; Schir E; Quesada JL; Mendoza C; Aspord C; Manches O; Coulie PG; Khammari A; Dreno B; Leccia MT; Plumas J
Oncoimmunology; 2020; 9(1):1738812. PubMed ID: 32313721
[TBL] [Abstract][Full Text] [Related]
8. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
Hubert P; Roncarati P; Demoulin S; Pilard C; Ancion M; Reynders C; Lerho T; Bruyere D; Lebeau A; Radermecker C; Meunier M; Nokin MJ; Hendrick E; Peulen O; Delvenne P; Herfs M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33712445
[TBL] [Abstract][Full Text] [Related]
9. [Anti-lung cancer effect of myeloid and plasmacytoid dendritic cell combined vaccines loaded with tumor cell lysates in vitro].
Tan JF; Zhong CH; Chen J; Guo QW; Kuang J; Zhang JH
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):501-507. PubMed ID: 31357836
[No Abstract] [Full Text] [Related]
10. Increased tumor-infiltrating plasmacytoid dendritic cells express high levels of PD-L2 and affect CD8
Ji Y; Heng Y; Zhu X; Zhang D; Tang D; Zhou J; Lin H; Ma J; Ding X; Tao L; Lu L
Transl Oncol; 2024 Jul; 45():101936. PubMed ID: 38678970
[TBL] [Abstract][Full Text] [Related]
11. Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer.
Kim CG; Kim G; Kim KH; Park S; Shin S; Yeo D; Shim HS; Yoon HI; Park SY; Ha SJ; Kim HR
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34907028
[TBL] [Abstract][Full Text] [Related]
12. CD11c+ and CD123+ dendritic cell subsets in peripheral blood of lung cancer patients.
Afifi SS; Helal AM
Egypt J Immunol; 2009; 16(2):9-15. PubMed ID: 22059349
[TBL] [Abstract][Full Text] [Related]
13. Blood immune cell biomarkers in lung cancer.
Riemann D; Cwikowski M; Turzer S; Giese T; Grallert M; Schütte W; Seliger B
Clin Exp Immunol; 2019 Feb; 195(2):179-189. PubMed ID: 30246868
[TBL] [Abstract][Full Text] [Related]
14. Level of plasmacytoid dendritic cells is increased in non-small cell lung carcinoma.
Shi W; Li X; Porter JL; Ostrodi DH; Yang B; Li J; Wang Y; Zhang J; Bai L; Jiao S
Tumour Biol; 2014 Mar; 35(3):2247-52. PubMed ID: 24136746
[TBL] [Abstract][Full Text] [Related]
15. Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm study.
Zahran AM; Hetta HF; Mansour S; Saad ES; Rayan A
Cancer Immunol Immunother; 2021 Mar; 70(3):733-742. PubMed ID: 32918587
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma.
Chevolet I; Speeckaert R; Schreuer M; Neyns B; Krysko O; Bachert C; Van Gele M; van Geel N; Brochez L
J Transl Med; 2015 Jan; 13():9. PubMed ID: 25592374
[TBL] [Abstract][Full Text] [Related]
17. Development, Function, and Clinical Significance of Plasmacytoid Dendritic Cells in Chronic Myeloid Leukemia.
Inselmann S; Wang Y; Saussele S; Fritz L; Schütz C; Huber M; Liebler S; Ernst T; Cai D; Botschek S; Brendel C; Calogero RA; Pavlinic D; Benes V; Liu ET; Neubauer A; Hochhaus A; Burchert A
Cancer Res; 2018 Nov; 78(21):6223-6234. PubMed ID: 30166420
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the Notch pathway aggravates airway inflammation by inhibiting regulatory T cell differentiation via regulation of plasmacytoid dendritic cells.
Qu SY; Ti XY; Zhang J; Wu CG
Scand J Immunol; 2020 May; 91(5):e12865. PubMed ID: 32185817
[TBL] [Abstract][Full Text] [Related]
19. Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells.
Raychaudhuri D; Bhattacharya R; Sinha BP; Liu CSC; Ghosh AR; Rahaman O; Bandopadhyay P; Sarif J; D'Rozario R; Paul S; Das A; Sarkar DK; Chattopadhyay S; Ganguly D
Front Immunol; 2019; 10():1878. PubMed ID: 31440253
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
Zhang Z; Yuan F; Chen R; Li Y; Ma J; Yan X; Wang L; Zhang F; Tao H; Guo D; Huang Z; Zhang S; Li X; Zhi X; Ge X; Hu Y; Wang J
Front Immunol; 2020; 11():1173. PubMed ID: 32587591
[No Abstract] [Full Text] [Related]
[Next] [New Search]
